 This study suggests that thymoglobulin may be effective in reducing delayed graft function in kidney transplant recipients, but it does not appear to reduce the risk of acute allograft rejection. Furthermore, thymoglobulin appears to increase the risk of thrombocytopenia and leukopenia. This article was authored by Heshmatala Shabazian, Ali Gorbani, Fatehme Hayati, and others.